402 related articles for article (PubMed ID: 28890183)
1. Radiomics Analysis on Ultrasound for Prediction of Biologic Behavior in Breast Invasive Ductal Carcinoma.
Guo Y; Hu Y; Qiao M; Wang Y; Yu J; Li J; Chang C
Clin Breast Cancer; 2018 Jun; 18(3):e335-e344. PubMed ID: 28890183
[TBL] [Abstract][Full Text] [Related]
2. Correlation of sonographic features of invasive ductal mammary carcinoma with age, tumor grade, and hormone-receptor status.
Aho M; Irshad A; Ackerman SJ; Lewis M; Leddy R; Pope TL; Campbell AS; Cluver A; Wolf BJ; Cunningham JE
J Clin Ultrasound; 2013 Jan; 41(1):10-7. PubMed ID: 22996916
[TBL] [Abstract][Full Text] [Related]
3. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
[TBL] [Abstract][Full Text] [Related]
4. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
5. The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients.
Stein RG; Wollschläger D; Kreienberg R; Janni W; Wischnewsky M; Diessner J; Stüber T; Bartmann C; Krockenberger M; Wischhusen J; Wöckel A; Blettner M; Schwentner L;
BMC Cancer; 2016 Jul; 16():459. PubMed ID: 27411945
[TBL] [Abstract][Full Text] [Related]
6. MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.
Holli-Helenius K; Salminen A; Rinta-Kiikka I; Koskivuo I; Brück N; Boström P; Parkkola R
BMC Med Imaging; 2017 Dec; 17(1):69. PubMed ID: 29284425
[TBL] [Abstract][Full Text] [Related]
7. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
[TBL] [Abstract][Full Text] [Related]
8. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
[TBL] [Abstract][Full Text] [Related]
9. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
10. Quantitative ultrasound as a predictor of node metastases and prognosis in patients with breast cancer.
Hashimoto H; Suzuki M; Oshida M; Nagashima T; Yagata H; Shishikura T; Imanaka N; Nakajima N
Breast Cancer; 2000; 7(3):241-6. PubMed ID: 11029805
[TBL] [Abstract][Full Text] [Related]
11. High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2/EGFR-positive subtypes.
Chang HY; Tseng YK; Chen YC; Shu CW; Lin MI; Liou HH; Fu TY; Lin YC; Ger LP; Yeh MH; Liu PF
Surg Oncol; 2018 Jun; 27(2):314-320. PubMed ID: 29937187
[TBL] [Abstract][Full Text] [Related]
12. The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases.
Wojcinski S; Stefanidou N; Hillemanns P; Degenhardt F
BMC Womens Health; 2013 Nov; 13():47. PubMed ID: 24252758
[TBL] [Abstract][Full Text] [Related]
13. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
14. Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance?
Killelea BK; Chagpar AB; Bishop J; Horowitz NR; Christy C; Tsangaris T; Raghu M; Lannin DR
Ann Surg Oncol; 2013 Oct; 20(10):3247-53. PubMed ID: 23975299
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic Subtypes of Breast Cancers Initially Assessed as Probably Benign or of Low Suspicion on Ultrasonography Differ According to Tumor Size.
Koh J; Kim MJ; Moon HJ; Yoon JH; Park VY; Kim EK
J Ultrasound Med; 2018 Jun; 37(6):1503-1509. PubMed ID: 29148091
[TBL] [Abstract][Full Text] [Related]
16. Non-histopathological parameters associated with upgrade of breast tumours yielding a core biopsy report of histological grade 2 ductal no special type to grade 3 on excision.
Ahmeidat H; Purdie C; Jordan L; Fleming D; McCullough J; Evans A
Eur J Surg Oncol; 2018 Nov; 44(11):1720-1724. PubMed ID: 30150157
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic subtypes and tumor grades in breast cancer are associated with distinct 3-D power Doppler sonographic vascular features.
Chang YC; Huang YS; Huang CS; Chen JH; Chang RF
Eur J Radiol; 2014 Aug; 83(8):1368-74. PubMed ID: 24932848
[TBL] [Abstract][Full Text] [Related]
18. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer.
Çelebi F; Pilancı KN; Ordu Ç; Ağacayak F; Alço G; İlgün S; Sarsenov D; Erdoğan Z; Özmen V
Diagn Interv Radiol; 2015; 21(6):448-53. PubMed ID: 26359880
[TBL] [Abstract][Full Text] [Related]
19. Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer.
Zhou J; Jin AQ; Zhou SC; Li JW; Zhi WX; Huang YX; Zhu Q; Qian L; Wu J; Chang C
BMC Med Imaging; 2021 Dec; 21(1):184. PubMed ID: 34856951
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
Namura M; Tsunoda H; Yagata H; Hayashi N; Yoshida A; Morishita E; Takei J; Suzuki K; Yamauchi H
Clin Breast Cancer; 2018 Apr; 18(2):128-134. PubMed ID: 28843513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
